4.5 Article

Golgi enlargement in Arf-depleted yeast cells is due to altered dynamics of cisternal maturation

Journal

JOURNAL OF CELL SCIENCE
Volume 127, Issue 1, Pages 250-257

Publisher

COMPANY OF BIOLOGISTS LTD
DOI: 10.1242/jcs.140996

Keywords

Organelle size; Organelle number; Golgi; Cisternal maturation; Arf

Categories

Funding

  1. Department of Biotechnology [102/IFD/SAN/2282/2012-2013]
  2. Council of Scientific and Industrial Research [20-6/2009 (i) EU-IV, 37(1553)112/EMR-II]
  3. Advanced Centre for Treatment, Research and Education in Cancer
  4. National Institutes of Health [R01 GM061156, R01 GM104010, T32 GM007183]

Ask authors/readers for more resources

Regulation of the size and abundance of membrane compartments is a fundamental cellular activity. In Saccharomyces cerevisiae, disruption of the ADP-ribosylation factor 1 (ARF1) gene yields larger and fewer Golgi cisternae by partially depleting the Arf GTPase. We observed a similar phenotype with a thermosensitive mutation in Nmt1, which myristoylates and activates Arf. Therefore, partial depletion of Arf is a convenient tool for dissecting mechanisms that regulate Golgi structure. We found that in arf1 Delta cells, late Golgi structure is particularly abnormal, with the number of late Golgi cisternae being severely reduced. This effect can be explained by selective changes in cisternal maturation kinetics. The arf1 Delta mutation causes early Golgi cisternae to mature more slowly and less frequently, but does not alter the maturation of late Golgi cisternae. These changes quantitatively explain why late Golgi cisternae are fewer in number and correspondingly larger. With a stacked Golgi, similar changes in maturation kinetics could be used by the cell to modulate the number of cisternae per stack. Thus, the rates of processes that transform a maturing compartment can determine compartmental size and copy number.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

Sorting nexin 5 mediates virus-induced autophagy and immunity

Xiaonan Dong, Yuting Yang, Zhongju Zou, Yuting Zhao, Bo Ci, Lin Zhong, Madhura Bhave, Liwei Wang, Yi-Chun Kuo, Xiao Zang, Rui Zhong, Elizabeth R. Aguilera, R. Blake Richardson, Boris Simonetti, John W. Schoggins, Julie K. Pfeiffer, Li Yu, Xuewu Zhang, Yang Xie, Sandra L. Schmid, Guanghua Xiao, Paul A. Gleeson, Nicholas T. Ktistakis, Peter J. Cullen, Ramnik J. Xavier, Beth Levine

Summary: Autophagy plays a crucial role in immunity, especially in initiating autophagy during viral infection. SNX5 activates the PI3KC3 complex on endosomes to promote the initiation of autophagy, which is important for cellular defense against viral infections.

NATURE (2021)

Article Oncology

Role for the Histone Demethylase KDM4B in Rhabdomyosarcoma via CDK6 and CCNA2: Compensation by KDM4A and Apoptotic Response of Targeting Both KDM4B and KDM4A

Zoe S. Walters, Ewa Aladowicz, Barbara Villarejo-Balcells, Gary Nugent, Joanna L. Selfe, Paul Eve, Julian Blagg, Olivia Rossanese, Janet Shipley

Summary: Rhabdomyosarcomas (RMS) are soft tissue sarcomas predominantly found in children, and current treatments have severe side effects and poor outcomes, necessitating the discovery of novel, more targeted therapies. High expression of histone demethylases, particularly KDM4B, supports proliferation of RMS cells, and sustained knockdown of KDM4B can lead to functional compensation by KDM4A. Targeting both KDM4A and KDM4B is shown to be effective in killing RMS cells and overcoming functional redundancy in order to elicit strong therapeutic responses.

CANCERS (2021)

Review Rheumatology

The dynamic organelle primary cilia: emerging roles in organ fibrosis

Dibyendu Bhattacharyya, Maria E. Teves, John Varga

Summary: Primary cilia play a crucial role in the development of fibrosis, influencing the transition of mesenchymal progenitor cells to myofibroblasts. Recent studies have shown that alterations in primary cilia can impact the process of myofibroblast transition, suggesting potential new approaches for fibrosis prevention and treatment. Further research on the mechanisms involving primary cilia may provide valuable insights into the pathogenesis of fibrosis.

CURRENT OPINION IN RHEUMATOLOGY (2021)

Article Chemistry, Medicinal

Into Deep Water: Optimizing BCL6 Inhibitors by Growing into a Solvated Pocket

Matthew G. Lloyd, Rosemary Huckvale, Kwai-Ming J. Cheung, Matthew J. Rodrigues, Gavin W. Collie, Olivier A. Pierrat, Mahad Gatti Iou, Michael Carter, Owen A. Davis, P. Craig McAndrew, Emma Gunnell, Yann-Vai Le Bihan, Rachel Talbot, Alan T. Henley, Louise D. Johnson, Angela Hayes, Michael D. Bright, Florence Raynaud, Mirco Meniconi, Rosemary Burke, Rob L. M. van Montfort, Olivia W. Rossanese, Benjamin R. Bellenie, Swen Hoelder

Summary: Optimization of modestly active starting points led to potent inhibitors of BCL6 by perturbing a water network and forming new interactions, ultimately achieving a 100-fold improvement in activity. The most potent compounds displaced three of the five initial water molecules and formed hydrogen bonds with the remaining two, showing promising inhibition of BCL6 in cells and satisfactory pharmacokinetic properties for compound 25.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Multidisciplinary Sciences

Structural basis of the P4B ATPase lipid flippase activity

Lin Bai, Bhawik K. Jain, Qinglong You, H. Diessel Duan, Mehmet Takar, Todd R. Graham, Huilin Li

Summary: This study reports the structure of the P4B ATPase Neo1 in several states, clarifying its substrate transport mechanism and revealing similar functional intermediate states to dimeric flippases. The findings suggest that evolutionarily distant P4 ATPases use a structurally conserved mechanism for substrate transport.

NATURE COMMUNICATIONS (2021)

Article Chemistry, Medicinal

Improved Binding Affinity and Pharmacokinetics Enable Sustained Degradation of BCL6 In Vivo

Rosemary Huckvale, Alice C. Harnden, Kwai-Ming J. Cheung, Olivier A. Pierrat, Rachel Talbot, Gary M. Box, Alan T. Henley, Alexis K. de Haven Brandon, Albert E. Hallsworth, Michael D. Bright, Hafize Aysin Akpinar, Daniel S. J. Miller, Dalia Tarantino, Sharon Gowan, Angela Hayes, Emma A. Gunnell, Alfie Brennan, Owen A. Davis, Louise D. Johnson, Selby de Klerk, Craig McAndrew, Yann-Vai Le Bihan, Mirco Meniconi, Rosemary Burke, Vladimir Kirkin, Rob L. M. van Montfort, Florence I. Raynaud, Olivia W. Rossanese, Benjamin R. Bellenie, Swen Hoelder

Summary: This study optimized a benzimidazolone molecular glue-type degrader, leading to the development of a highly potent probe CCT373566 for sustained depletion of BCL6. The research discovered a sharp degradation SAR and demonstrated the impact of subtle structural changes on the ability to induce degradation of BCL6. In a lymphoma xenograft mouse model, CCT373566 showed modest in vivo efficacy following oral dosing.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Optimizing Shape Complementarity Enables the Discovery of Potent Tricyclic BCL6 Inhibitors

Owen A. Davis, Kwai-Ming J. Cheung, Alfie Brennan, Matthew G. Lloyd, Matthew J. Rodrigues, Olivier A. Pierrat, Gavin W. Collie, Yann-Vai Le Bihan, Rosemary Huckvale, Alice C. Harnden, Ana Varela, Michael D. Bright, Paul Eve, Angela Hayes, Alan T. Henley, Michael D. Carter, P. Craig McAndrew, Rachel Talbot, Rosemary Burke, Rob L. M. van Montfort, Florence Raynaud, Olivia W. Rossanese, Mirco Meniconi, Benjamin R. Bellenie, Swen Hoelder

Summary: A new chemical series with enhanced binding affinity to the BTB domain of B-cell lymphoma 6 protein was identified by ring fusion onto a quinolinone lead series. This was achieved by attaining close shape complementarity and a conformationally restricted core, resulting in potent BCL6 inhibitors.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

ER exit sites (ERES) and ER-mitochondria encounter structures (ERMES) often localize proximally

Naini Chakraborty, Bhawik Kumar Jain, Samruddhi Shembekar, Dibyendu Bhattacharyya

Summary: This study investigates the potential functional link between ER-mitochondria encounter structures (ERMES) and ER exit sites (ERES). The disruption of either ERMES or ERES affects the other, and a chaperone protein, Djp1, is found to regulate mitochondrial protein import in the ERES-ERMES proximal region.

FEBS LETTERS (2023)

Article Immunology

Lipid Transport by Candida albicans Dnf2 Is Required for Hyphal Growth and Virulence

Bhawik K. Jain, Andrew S. Wagner, Todd B. Reynolds, Todd R. Graham

Summary: Candida albicans is a common cause of human mucosal yeast infections, and antifungal medications targeting the pathogen cell wall or plasma membrane have been effective. This study shows that the transport of glucosylceramide (GIcCer) and/or phosphatidylcholine (PC) by plasma membrane P4-ATPases is important for the pathogenicity of Candida albicans. The mutant strains lacking Dnf2 protein exhibit defects in yeast-to-hypha growth transition, filamentous growth, and virulence in systemically infected mice.

INFECTION AND IMMUNITY (2022)

Article Multidisciplinary Sciences

Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs

Wenxia Wang, Swarna Bale, Jun Wei, Bharath Yalavarthi, Dibyendu Bhattacharyya, Jing Jing Yan, Hiam Abdala-Valencia, Dan Xu, Hanshi Sun, Roberta G. Marangoni, Erica Herzog, Sergejs Berdnikovs, Stephen D. Miller, Amr H. Sawalha, Pei-Suen Tsou, Kentaro Awaji, Takashi Yamashita, Shinichi Sato, Yoshihide Asano, Chinnaswamy Tiruppathi, Anjana Yeldandi, Bettina C. Schock, Swati Bhattacharyya, John Varga

Summary: The reduced expression of A20 gene in systemic sclerosis (SSc) skin and lungs is associated with the development of fibrosis. The study suggests that A20 plays a critical role in restraining fibroblast activation and could be a potential target for fibrosis therapy.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assays

Olivier A. Pierrat, Manjuan Liu, Gavin W. Collie, Kartika Shetty, Matthew J. Rodrigues, Yann-Vai Le Bihan, Emma A. Gunnell, P. Craig McAndrew, Mark Stubbs, Martin G. Rowlands, Norhakim Yahya, Erald Shehu, Rachel Talbot, Lisa Pickard, Benjamin R. Bellenie, Kwai-Ming J. Cheung, Ludovic Drouin, Paolo Innocenti, Hannah Woodward, Owen A. Davis, Matthew G. Lloyd, Ana Varela, Rosemary Huckvale, Fabio Broccatelli, Michael Carter, David Galiwango, Angela Hayes, Florence Raynaud, Christopher Bryant, Steven Whittaker, Olivia W. Rossanese, Swen Hoelder, Rosemary Burke, Rob L. M. van Montfort

Summary: By recruiting corepressor proteins, B-cell lymphoma 6 (BCL6) protein controls gene transcription required for B-cell germinal center formation. This study aims to discover small molecule inhibitors that disrupt BCL6-corepressor protein interaction, as BCL6 deregulation is implicated in Diffuse Large B-Cell Lymphoma development. The researchers used high throughput screening and various assays to identify hit series, determined X-ray structures of BCL6 bound to compounds, and developed biochemical and cellular assays to optimize compound potency.

SCIENTIFIC REPORTS (2022)

Article Medicine, Research & Experimental

Deficiency of inhibitory TLR4 homolog RP105 exacerbates fibrosis

Wenxia Wang, Swarna Bale, Bharath Yalavarthi, Priyanka Verma, Pei-Suen Tsou, Ken M. Calderone, Dibyendu Bhattacharyya, Gary J. Fisher, John Varga, Swati Bhattacharyya

Summary: RP105 has been identified as a novel cell-intrinsic negative regulator of TLR4-MD2-driven sustained fibroblast activation, and its impaired function may contribute to the progression of systemic sclerosis.

JCI INSIGHT (2022)

Article Biochemistry & Molecular Biology

Reprogramming nucleolar size by genetic perturbation of the extranuclear Rab GTPases Ypt6 and Ypt32

Shreosi Chatterjee, Abira Ganguly, Dibyendu Bhattacharyya

Summary: This study investigates nucleolar size reprogramming in Saccharomyces cerevisiae mutants with opposite effects on nucleolar size. Mutations in genes involved in nuclear functions cause enlargement of nuclei/nucleoli, while mutations in secretory pathway family genes lead to reduced nucleolar size. Moreover, the combination of nucleolar size-reducing mutations and specific mutants can effectively reprogram the nuclear/nucleolar size almost back to normal.

FEBS LETTERS (2023)

Article Biochemistry & Molecular Biology

Encoding BRAF inhibitor functions in protein degraders

Daniel S. J. Miller, Sabine A. Voell, Izidor Sosic, Matic Proj, Olivia W. Rossanese, Gregor Schnakenburg, Michael Guetschow, Ian Collins, Christian Steinebach

Summary: A new generation of BRAF(V600E) degraders has been developed to avoid paradoxical activation of the MAPK pathway, providing a new approach for cancer therapy.

RSC MEDICINAL CHEMISTRY (2022)

No Data Available